PuSH - Publication Server of Helmholtz Zentrum München: The combination of crenolanib and azacitidine effectively targets leukemia-initiating cells in FLT3-ITD+ AML to overcome protection by the bone marrow niche.

Navigation

Research

Browse by ...

... Journal

Support & Contact

Garz, A.-K.* ; Weickert, M.-T.* ; Pagel, C.* ; Habringer, S.* ; Vick, B. ; Jeremias, I. ; Keller, U.* ; Oostendorp, R.* ; Peschel, C.* ; Goetze, K.*

The combination of crenolanib and azacitidine effectively targets leukemia-initiating cells in FLT3-ITD+ AML to overcome protection by the bone marrow niche.

Oncol. Res. Treat. 38, 214 (2015)

Open Access Green as soon as Postprint is submitted to ZB.

Altmetric

Additional Metrics?

Edit extra informations Login

Publication type Article: Journal article

Document type Meeting abstract

Corresponding Author

ISSN (print) / ISBN 2296-5270

e-ISSN 2296-5262

Quellenangaben Volume: 38, Pages: 214

Publisher Karger

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Research Unit Gene Vector (AGV)